Cite this article
Volume | Year
European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Axillary lymph node metastasis as first presentation of peritoneal carcinomatosis from serous papillary ovarian cancer: case report and review of the literature
S. Sibio1,*, P. Sammartino1, F. Accarpio1, M. L. Framarino dei Malatesta2, D. Biacchi1, B. M. Sollazzo1, A. Di Giorgio1
1 University “Sapienza” of Rome, Department of Surgery “Pietro Valdoni”, Eleonora Lorillard Spencer Cenci Foundation, Rome
2 University “Sapienza” of Rome, Department of Gynecological and Obstetrics Sciences and Urological Sciences, Rome (Italy)
Eur. J. Gynaecol. Oncol. 2014, 35(2), 170–173; https://doi.org/10.12892/ejgo24962014
Published: 10 April 2014
Ovarian cancer usually spreads into abdominal cavity and to the loco-regional lymph nodes. Extra-abdominal metastases are less frequent and isolated axillary metastases are very rare. The authors describe the case of a 49-year-old woman who was diagnosed with a peritoneal carcinomatosis from ovarian cancer by mean of an enlarged axillary lymph node biopsy, whose histological examination identified as a ovarian cancer metastasis. Patient was treated by peritonectomy and intraperitoneal chemohyperthermic perfusion (HIPEC). Although patients with axillary lymph node metastasis from ovarian cancer are though to be metastatic (FIGO Stage IV), surgical radical treatment and adjuvant systemic chemotherapy can achieve the same prognosis of Stage IIIb-c patients, suggesting they could be a particularly good prognosis subset of patients. Early differential diagnosis between ovarian or breast cancer in axillary lymph node metastasis is crucial but not always very simple, because of the very different course and treatment of these tumours.
Axillary lymph node metastasis